PanTheryx Stock
Intestinal health research, development, and commercialization products
Sign up today and learn more about PanTheryx Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About PanTheryx Stock
PanTheryx is a U.S. medical nutrition company focused on the research, development, and commercialization of products that promote intestinal health. The company is engaged in the discovery and development of its proprietary technology platform, advancing clinical testing, and the commercialization of its products that both address the specific dietary needs of children with infectious diarrhea, and support overall intestinal health. The company’s medical nutrition products are regulated in three FDA categories: medical foods, food for special dietary use, and dietary supplements. PanTheryx was founded in 2007 by Mark A. Braman and is based in Boulder, Colorado.
Investors
Funding History
March 2011 | $1.0M |
---|---|
December 2011 | $1.6M |
August 2012 | $3.5M |
April 2015 | $9.3M |
March 2016 | $53.0M |
September 2017 | $8.9M |
Management
CEO & President
Mark A. Braman
Vice President, Corporate Development and General Counsel
Scott Hyman
Executive Vice President
George Stagnitti
Press
bizjournals - Dec, 22 2023
These 5 Colorado companies raised the most capital in Octoberprnewswire - Dec, 22 2023
Digestive Health Supplements to grow by USD 7.86 billion ...bizwest - Nov, 29 2023
Boulder biotech firm PanTheryx raises $52Mbusinesswire - Jun, 27 2023
PanTheryx® Renews Exclusive Three-Year Partnership with VitaDairy® in Pediatric and Adult Immunonutrition